Intensity Therapeutics (INTS) Earnings Date & Reports
Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
INTS is expected to report earnings to fall 30.32% to -15 cents per share on August 18
Q2'25
Est.
$-0.15
Q1'25
Missed
by $0.04
Q4'24
Missed
by $0.95
Q3'24
Beat
by $0.06
Q2'24
Missed
by $0.04
The last earnings report on May 13 showed earnings per share of -21 cents, missing the estimate of -18 cents. With 63.01K shares outstanding, the current market capitalization sits at 8.52M.